Skip to Main Content

Browse issues

Volume 44, Issue suppl_1, February 2014

Surviving Cancer in Asia: Cross-boundary Cancer Studies, The University of Tokyo

Introduction

Hideyuki Akaza and Norie Kawahara
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i1–i2, https://doi.org/10.1093/jjco/hyt231

Knowledge for Understanding Cancer in Asia

Emiko Namihira
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i13–i16, https://doi.org/10.1093/jjco/hyt215
Sumio Sugano
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i17–i21, https://doi.org/10.1093/jjco/hyt221

Devising Models for a Rapidly Aging Asia

Tetsuo Tsuji
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i22–i27, https://doi.org/10.1093/jjco/hyt217
Yukio Hattori
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i28–i31, https://doi.org/10.1093/jjco/hyt211

Two Views Looking to the Future of Cancer in Asia

Hideyuki Akaza
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i3–i5, https://doi.org/10.1093/jjco/hyt228

How Do Cancer Researchers Perceive the Future of Cancer in Asia?

Masahiko Nishiyama
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i32–i37, https://doi.org/10.1093/jjco/hyt205
Tadao Kakizoe
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i38–i42, https://doi.org/10.1093/jjco/hyt206
Tetsuo Noda
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i43–i47, https://doi.org/10.1093/jjco/hyt216

What Contribution Can Pharmaceutical Companies Make to Cancer in Asia?

Masuhiro Kato
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i48–i53, https://doi.org/10.1093/jjco/hyt208
Pascal Rigaudy
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i54–i59, https://doi.org/10.1093/jjco/hyt207

Two Views Looking to the Future of Cancer in Asia

Norie Kawahara
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i6–i7, https://doi.org/10.1093/jjco/hyt229

What Contribution Can Pharmaceutical Companies Make to Cancer in Asia?

Masafumi Nogimori
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i60–i64, https://doi.org/10.1093/jjco/hyt218

What Efforts Should be made in Asia in a Globalizing World?

Keizo Takemi
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i65–i68, https://doi.org/10.1093/jjco/hyt209
Kenji Shibuya
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i69–i73, https://doi.org/10.1093/jjco/hyt219
Yohei Sasakawa
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i74–i77, https://doi.org/10.1093/jjco/hyt210
Shotaro Yachi
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i78–i83, https://doi.org/10.1093/jjco/hyt220

Knowledge for Understanding Cancer in Asia

Shunya Yoshimi
Japanese Journal of Clinical Oncology, Volume 44, Issue suppl_1, February 2014, Pages i8–i12, https://doi.org/10.1093/jjco/hyt214
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close